Submitted by dcc on Mon, 2020-02-10 11:37 Study Title: A Phase II Randomized Trial of Olaparib Versus Olaparib Plus Tremelimumab In Platinum-Sensitive Recurrent Ovarian CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: NRGStatus: ActiveReview Status: Available to Open
